News & Press Releases

Member Theresa Carnegie was quoted by Managed Healthcare Executive in an article about new bill Break Up Big Medicine Act that proposes a separation of the largest insurance companies and pharmacy benefit managers.  

Mintz’s Sustainable Energy & Infrastructure Practice advised on $5.6 billion in deals in 2025, closing over 60 transactions and marking over 200 completed transactions in the last three years. The team also commemorated 20 years since it was launched as the legal industry’s first integrated practice dedicated to the energy transition.

Law360 Healthcare Authority featured insights from Member Theresa Carnegie in an article focused on the Consolidated Appropriations Act of 2026 which introduces new regulations for pharmacy benefit managers, particularly aimed at fee and cost transparency.

Mintz advised Satellos Bioscience Inc. in its US$57.2 million public offering in the United States and Canada and the concurrent listing of its common shares on the Nasdaq Global Market under the trading symbol “MSLE”.  Satellos’ common shares are also listed on the Toronto Stock Exchange under the trading symbol “MSCL”. 

Competition Policy International featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.

The American Lawyer featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan. The article highlights the team’s focus on high-stakes disputes, including representing major corporations in antitrust opt-out cases, and explains why Mintz was the right fit.